Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Teva Announces The Launch Of Generic Vagifem In The United States July 24, 2017 Eli Lilly Quietly Works on Wearable Devices in Lab Established in 2015 November 21, 2017 FDA to Publicly Disclose Advisory Committee Members' CVs February 7, 2017